Computer-based Neurocognitive Assessment in Children With Central Nervous System Tumors Receiving Proton Beam Radiation Therapy

Purpose

This study will explore neurocognitive performance in pediatric brain tumor patients receiving proton beam radiation therapy (PBRT). The investigators goal is to gather baseline neurocognitive testing prior to the completion of the first week of radiation therapy along with follow-up testing 6-12 months after the completion of radiation and serial annual testing thereafter. With these data the investigators plan to evaluate the effects of PBRT on neurocognitive performance as it relates to patients' age at diagnosis, tumor location, and radiation dose. Modeling studies have demonstrated that PBRT could improve neurocognitive outcomes, but there is a paucity of prospectively-collected patient data. The investigators are uniquely positioned to address this important question given the busy pediatric central nervous system (CNS) tumor service, the delivery of proton therapy at the S. Lee Kling Proton Therapy Center at Barnes-Jewish Hospital, and the multi-disciplinary research team with extensive experience into the late effects of therapy as it relates to neurocognition.

Condition

  • Central Nervous System

Eligibility

Eligible Ages
Between 4 Years and 21 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Criteria

Inclusion Criteria:

- Diagnosis of primary CNS tumor or diagnosis of metastatic disease to the CNS with an
expected overall survival of > 1 year. Any prior treatment (chemo, XRT, or surgery)
is allowed.

- Planning to receive PBRT to treat the CNS tumor. Patients who have already received
PBRT for this disease may also be enrolled provided they completed the NIH Toolbox
Cognitive Battery prior to the first week of radiation therapy.

- Between 4 and 21 years of age (inclusive).

- Life expectancy of at least one year.

- Absence of visual impairment that would impede computer testing.

- No secondary health conditions that would impact cognitive functioning (e.g.
psychiatric or developmental disability unrelated to cancer).

- Able to understand and willing to sign IRB-approved written informed consent
document (or signature of legally authorized representative).

Study Design

Phase
Study Type
Observational
Observational Model
Case-Only
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
Arm 1: NIH Toolbox Cognitive Battery testing - This study will use the NIH Toolbox Cognitive Battery computer testing software to investigate the cognitive outcomes in children with CNS tumors receiving PBRT. - Participants recruited for the study will complete one 45-minute testing session prior to the completion of the first week of radiation therapy. - They will then complete serial tests 6-12 months after the completion of PBRT and then yearly thereafter.
  • Other: NIH Toolbox Cognitive Battery
    - For ages 4 to 7 years, the NIH Toolbox Early Childhood Battery will be administered. This test includes the Picture Vocabulary, Flanker Inhibitory Control and Attention, Dimensional Change Card Sort, and Picture Sequence Memory measures to evaluate language, executive function, attention, and episodic memory, respectively. - For patients age 8 years or older, the administered battery will consist of the aforementioned tests in addition to Oral Reading Recognition, Pattern Comparison Processing Speed, and List Sort Working Memory tests. Results will include scores for each individual measure. In addition, each cognition battery provides composite scores, which allow for general interpretation/evaluation of overall cognitive functioning.

Recruiting Locations

Washington University in St. Louis and nearby locations

Washington University School of Medicine
St Louis 4407066, Missouri 4398678 63110
Contact:
Stephanie Perkins, M.D.
314-747-4405
sperkins@wustl.edu

More Details

NCT ID
NCT02559752
Status
Recruiting
Sponsor
Washington University School of Medicine

Study Contact

Stephanie Perkins, M.D.
314-747-4405
sperkins@wustl.edu